139 related articles for article (PubMed ID: 8403512)
1. Blockade of immunoregulatory Fc-signalling by HIV peptides: oligopeptides from HIV gp120 and gp41 bind the Fc portion of IgG and increase the in vitro anti-ssDNA response.
Rahimpour R; Anderson CC; Sinclair NR
Clin Exp Immunol; 1993 Oct; 94(1):26-31. PubMed ID: 8403512
[TBL] [Abstract][Full Text] [Related]
2. Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope protein.
Haynes BF; Arthur LO; Frost P; Matthews TJ; Langlois AJ; Palker TJ; Hart MK; Scearce RM; Jones DM; McDanal C
J Exp Med; 1993 Mar; 177(3):717-27. PubMed ID: 7679708
[TBL] [Abstract][Full Text] [Related]
3. Immunoregulatory characteristics of the in vitro anti-ssDNA response.
Anderson CC; Panoskaltsis A; Sinclair NR
Immunol Res; 1993; 12(4):349-57. PubMed ID: 8151158
[TBL] [Abstract][Full Text] [Related]
4. Anti-IgG autoantibodies in HIV-infected hemophilia patients.
Süsal C; Lewin IV; Stanworth DR; Terness P; Daniel V; Oberg HH; Huth-Kühne A; Zimmermann R; Opelz G
Vox Sang; 1992; 62(4):224-9. PubMed ID: 1642003
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of immunoglobulin production in vitro by IgG and F(ab')2 fragments, but not by the Fc portion.
Klaesson S; Tammik L; Markling L; Lundkvist I; Ringdén O
Scand J Immunol; 1996 May; 43(5):574-82. PubMed ID: 8633217
[TBL] [Abstract][Full Text] [Related]
6. An HIV Envelope gp120-Fc Fusion Protein Elicits Effector Antibody Responses in Rhesus Macaques.
Shubin Z; Li W; Poonia B; Ferrari G; LaBranche C; Montefiori D; Zhu X; Pauza CD
Clin Vaccine Immunol; 2017 Jun; 24(6):. PubMed ID: 28404572
[TBL] [Abstract][Full Text] [Related]
7. Sequestration of anti-platelet GPIIIa antibody in rheumatoid factor immune complexes of human immunodeficiency virus 1 thrombocytopenic patients.
Karpatkin S; Nardi MA; Hymes KB
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2263-7. PubMed ID: 7892259
[TBL] [Abstract][Full Text] [Related]
8. Bispecific antibody targeting of human immunodeficiency virus type 1 (HIV-1) glycoprotein 41 to human macrophages through the Fc IgG receptor I mediates neutralizing effects in HIV-1 infection.
Mabondzo A; Aussage P; Bartholeyns J; Le Naour R; Raoul H; Romet-Lemonne JL; Dormont D
J Infect Dis; 1992 Jul; 166(1):93-9. PubMed ID: 1535093
[TBL] [Abstract][Full Text] [Related]
9. IgA Targeting Human Immunodeficiency Virus-1 Envelope gp41 Triggers Antibody-Dependent Cellular Cytotoxicity Cross-Clade and Cooperates with gp41-Specific IgG to Increase Cell Lysis.
Duchemin M; Khamassi M; Xu L; Tudor D; Bomsel M
Front Immunol; 2018; 9():244. PubMed ID: 29651286
[TBL] [Abstract][Full Text] [Related]
10. Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1.
Gohain N; Tolbert WD; Acharya P; Yu L; Liu T; Zhao P; Orlandi C; Visciano ML; Kamin-Lewis R; Sajadi MM; Martin L; Robinson JE; Kwong PD; DeVico AL; Ray K; Lewis GK; Pazgier M
J Virol; 2015 Sep; 89(17):8840-54. PubMed ID: 26085162
[TBL] [Abstract][Full Text] [Related]
11. Increase in the immunogenicity of HIV peptide antigens by chemical linkage to polytuftsin (TKPR40).
Gokulan K; Khare S; Rao DN
DNA Cell Biol; 1999 Aug; 18(8):623-30. PubMed ID: 10463058
[TBL] [Abstract][Full Text] [Related]
12. Fc-dependent IgG-mediated suppression of the antibody response: fact or artefact?
Heyman B
Scand J Immunol; 1990 May; 31(5):601-7. PubMed ID: 1693227
[TBL] [Abstract][Full Text] [Related]
13. The Fc portion of intact IgG blocks stimulation of human PBMC by anti-T3.
Looney RJ; Abraham GN
J Immunol; 1984 Jul; 133(1):154-6. PubMed ID: 6609973
[TBL] [Abstract][Full Text] [Related]
14. The C4 region as a target for HIV entry inhibitors--NMR mapping of the interacting segments of T20 and gp120.
Moseri A; Biron Z; Arshava B; Scherf T; Naider F; Anglister J
FEBS J; 2015 Dec; 282(24):4643-57. PubMed ID: 26432362
[TBL] [Abstract][Full Text] [Related]
15. Increased immunogenicity of human immunodeficiency virus gp120 engineered to express Galalpha1-3Galbeta1-4GlcNAc-R epitopes.
Abdel-Motal U; Wang S; Lu S; Wigglesworth K; Galili U
J Virol; 2006 Jul; 80(14):6943-51. PubMed ID: 16809300
[TBL] [Abstract][Full Text] [Related]
16. Anti-F(ab')2 antibody in HIV type 1 infection: relationship to hypergammaglobulinemia and to antibody specific to the V3 loop region of glycoprotein 120.
Morrison SA; Pearson SL; Steigbigel RT
AIDS Res Hum Retroviruses; 1998 Apr; 14(6):491-8. PubMed ID: 9566551
[TBL] [Abstract][Full Text] [Related]
17. A recombinant mimetics of the HIV-1 gp41 prehairpin fusion intermediate fused with human IgG Fc fragment elicits neutralizing antibody response in the vaccinated mice.
Qi Z; Pan C; Lu H; Shui Y; Li L; Li X; Xu X; Liu S; Jiang S
Biochem Biophys Res Commun; 2010 Jul; 398(3):506-12. PubMed ID: 20599765
[TBL] [Abstract][Full Text] [Related]
18. Human IgG anti-F(ab')2 antibodies possess rheumatoid factor activity.
Hunt Gerardo S; Persselin JE; Stevens RH
Clin Exp Immunol; 1990 Aug; 81(2):293-300. PubMed ID: 1696866
[TBL] [Abstract][Full Text] [Related]
19. B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19- to 36-residue) synthetic peptides.
Neurath AR; Strick N; Lee ES
J Gen Virol; 1990 Jan; 71 ( Pt 1)():85-95. PubMed ID: 1689372
[TBL] [Abstract][Full Text] [Related]
20. IFN-gamma restores HIV- and non-HIV-specific cell mediated immune response in vitro and its activity is neutralized by antibodies from patients with AIDS.
De Francesco MA; Caruso A; Dima F; Cantalamessa A; Canaris AD; Folghera S; Fiorentini S; Flamminio G; Licenziati S; Peroni L; Gao J; Garotta G; Turano A
Scand J Immunol; 1996 Jan; 43(1):94-100. PubMed ID: 8560203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
